News Content
Its core mechanism is "hierarchical regulation": After gonadorelin binds to pituitary gonadotropin cell receptors, it triggers the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These two hormones then act on the gonads-in men, they promote testosterone synthesis in the testes; clinical data show that testosterone levels begin to rise 15-30 minutes after intravenous injection, reaching a peak within 1-2 hours, with an increase of 30%-50%; in women, it regulates follicle development and the secretion of estrogen and progesterone, laying the foundation for ovulation.https://www.fiercerawsource.com/peptides/premium-high-purity-peptides-gonadorelin-2mg.html
In clinical applications, it has both therapeutic and diagnostic value. For patients with hypothalamic hypogonadism, regular injections can restart hormone secretion pathways, helping men restore libido and women establish normal menstrual cycles. In the field of assisted reproduction, it is often used as a "starter" for ovulation induction protocols, increasing the proportion of high-quality follicles by steadily regulating FSH levels. Diagnostively, monitoring the response to LH and FSH after injection can differentiate whether hypogonadism originates from the hypothalamus, pituitary gland, or the gonads themselves.
It is important to note that short-term use may cause mild discomfort such as hot flashes and bloating, while long-term excessive use may suppress endocrine secretion through negative feedback. Endocrinologists emphasize: "It is a precise 'signal regulator,' and medication should be individualized based on hormone test results to avoid blind use that could disrupt the reproductive axis balance."
